Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

Podobne knjige/članki

• Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
  od: Pollock, Richard F., et al.
  Izdano: (2019)
• Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials
  od: Wolf, Myles, et al.
  Izdano: (2020)
• Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
  od: Kanshaiym, Sakiyeva, et al.
  Izdano: (2020)
• Management of iron deficiency anemia in inflammatory bowel disease – a practical approach
  od: Stein, Jürgen, et al.
  Izdano: (2013)
• Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
  od: Melvin H. Seid, et al.
  Izdano: (2017-01-01)